Get Pharma & Biotech every Monday

One free email with what the biggest companies in Pharma & Biotech filed, were granted and gave up this week.

The Thicket.
Pharma & Biotech / Week of Nov 16, 2026Get it every Monday →
All Pharma & BiotechIssue 001 / Bristol-Myers SquibbThe filing
Bristol-Myers SquibbGrant

Bristol-Myers Squibb secures patents on TREM-1 and Vista antibodies while publishing CD3 and CD19 bispecifics.

The filing

Bristol-Myers Squibb was granted US patents on November 10, 2026, for antibodies against human TREM-1 and for antibodies binding to Vista at acidic pH. The company also published applications on November 12, 2026, for CD3 binding molecules and for CD19 binding molecules including CD3- and CD19-bispecific T cell engagers.

This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.

Expert view

BRISTOL-MYERS SQUIBB COMPANY was granted US patent 12790392 (opens in a new tab), titled "ANTIBODIES AGAINST HUMAN TREM-1 AND USES THEREOF", on November 10, 2026. Bristol-Myers Squibb Company was granted US patent 12790396 (opens in a new tab), titled "Antibodies Binding to Vista at Acidic pH", on November 10, 2026. Bristol-Myers Squibb Company's application US20260356948A1 (opens in a new tab), titled "CD3 BINDING MOLECULES AND RELATED METHODS AND USES", was published on November 12, 2026. Bristol-Myers Squibb Company's application US20260356949A1 (opens in a new tab), titled "CD19 BINDING MOLECULES INCLUDING CD3- AND CD19- BISPECIFIC T CELL ENGAGERS AND RELATED METHODS AND USES", was published on November 12, 2026.

Get Pharma & Biotech every Monday.

© 2026 Fearn AI, Inc. All rights reserved.

Information from the public patent record, not legal advice.

Big Law patents. In plain sight.

The all-in-one patent firm for startups. Former Big Law patent experts and PhDs, on AI that runs on our own GPUs.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.

Big Law patents. In plain sight.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.

Big Law patents. In plain sight.

The all-in-one patent firm for startups. Former Big Law patent experts and PhDs, on AI that runs on our own GPUs.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.